Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

87.5%

+1.0% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

1(12.5%)

Phase 1

1(12.5%)

8Total

N/A(6)

Phase 3(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04180254Not ApplicableCompleted

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments Study 3 (HEAR3D_CE3)

Role: collaborator

NCT03774030Not ApplicableCompleted

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments Study 2

Role: collaborator

NCT02694614Not ApplicableCompleted

Weight-loss Treatment Through Smartphone-assisted Dietary Coaching

Role: collaborator

NCT03514758Not ApplicableCompleted

Evaluation and Optimization of Hearing Devices in 3-D Complex Audio Environments

Role: collaborator

NCT02189551Not ApplicableTerminated

Advanced Robotic Training With Additional Degrees of Freedom: Towards a Free-walking System

Role: collaborator

NCT02911298Phase 1Completed

Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules

Role: collaborator

NCT01774669Phase 3Completed

Effectiveness Study on a Virtual Reality Based Training System for Stroke Patients

Role: collaborator

NCT02563886Not ApplicableUnknown

Electrically Assisted Movement Therapy

Role: collaborator

NCT01436344Completed

Markers of Paroxysmal Atrial Fibrillation in Esophageal Holter Electrocardiography

Role: collaborator

All 9 trials loaded